Navigation Links
New surgical technique for removing inoperable tumors of the abdomen
Date:5/1/2012

Abdominal tumors involving both roots of the celiac and superior mesenteric artery (SMA) are deemed unresectable by conventional surgical methods, as removal would cause necrosis of the organs that are supplied by those blood vessels.

A case report published in the journal American Journal of Transplantation presents a novel surgical technique that enables surgeons to remove tumors that are unresectable by the usual surgical techniques.

Led by Tomoaki Kato, MD, FACS, of Columbia University, surgeons removed tumors in 3 patients involving both the celiac artery and SMA using new surgical techniques never performed before, known as "ex vivo" surgery where the organs are removed to do surgery.

First, surgeons removed entire abdominal organs together with the tumor. The patient is "organless" during this period. The tumor was cut and blood vessels were reconstructed using synthetic vascular grafts. Surgeons then re-implanted the organs back into the patient's abdomen, connecting blood vessels and gastrointestinal tracts.

Surgery was successful, and all 3 patients are alive with no tumor recurrence to date after 2 to 4 years from the surgery.

"Our technique appears both feasible and effective in the proper clinical situation when performed by a multidisciplinary team experienced in multivisceral transplantation," Kato notes. "This technique can expand the role of transplant surgery in specific oncological problem, and more patients with 'inoperable' tumors can be operated."


'/>"/>

Contact: Amy Molnar
healthnews@wiley.com
201-748-8844
Wiley-Blackwell
Source:Eurekalert

Page: 1

Related medicine news :

1. 2010 HSR Impact Award recognizes surgical safety research
2. Annals of Surgical Oncology adds new society affiliation
3. Medicare data reveals differences in orthopedic surgical outcomes
4. Is a Tummy Tuck Right for Me? Alabama Plastic Surgeon Dr. David Durst Offers Tips as the Popularity of Surgical Cosmetic Enhancement Continues to Rise
5. Two Surgical Methods Equally Successful for Prostate Cancer
6. Surgical Information Systems Introduces SIS OR View to Maximize Communication and Improve Patient Safety in the Operating Room
7. Delaying post-surgical radiation increases risk of breast cancer recurrence in older women
8. Florida Surgeon Demonstrates Kidney Sparing Cancer Treatment in Live Surgical Webcast
9. National Institutes of Health Awards Kitware Over $600,000 to Develop Advancements in Neurosurgical Simulation
10. Medical Ultrasound Now Used in New, Non-surgical Cosmetic Procedure
11. Eisner USA, LLC Collaborates with Surgical Review Corp to Provide Innovative Bariatric Devices to Bariatric Surgery Center of Excellence (BSCOE) Participants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... modern procedure that achieves results in a fraction of the time as traditional ... NV, with Significance Dental Specialists, now offers this revolutionary treatment with or without ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America ... with a reputable physician in their area, announces the launch of a new and ... patients who are looking for reputable physicians to help them with back or neck ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS Healthcare Solutions ... (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. , BYOD ... devices with a pre-programmed tablet in a remarkably easy-to-use kit for patients. “BYOD ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
Breaking Medicine Technology: